| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J31-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-0031 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J71-00 |
| filingDate |
1974-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f25ce0c30fc84f55c89a7c20a26d7cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71d01354d94af5f82779bcd9019cac9a |
| publicationDate |
1976-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-2433148-A1 |
| titleOfInvention |
MEDICINAL PRODUCTS FOR INCREASING HOPE FORMATION |
| abstract |
The compsn. contains as active ingredient a water-soluble corticoid ester of formula (I): (X = H, F or CH3; Y = H, F or Cl; R1 = 2H, CH3 plus H, or =CH2; R2=OH; or R1+R2 are together 16 alpha, 17 alpha-isopropylidenedioxy plus 16 beta-H; M = alkali metal). Cpds. (I) significantly increase erythropoesis and can be used to treat hypoplastic anaemia and panmyelopathia. They are not anabolic. Usual dose is 10-500 mg/day (up to 2500 mg/day in extreme cases) pref. administered by long-term i.v. infusion. |
| priorityDate |
1974-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |